Mitochondria as a pharmacological target: magnum overview.
about
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis PathwayMitochondrial targets for pharmacological intervention in human diseasePrimary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentMitochondrial targeted β-lapachone induces mitochondrial dysfunction and catastrophic vacuolization in cancer cellsPoisoning of mitochondrial topoisomerase I by lamellarin DNovel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.Synthesis of hydroxycinnamic acid derivatives as mitochondria-targeted antioxidants and cytotoxic agents.Targeting cardiac potassium channels for state-of-the-art drug discovery.Mechanisms by which different functional states of mitochondria define yeast longevity.Development and characterization of mitochondrial membrane affinity chromatography columns derived from skeletal muscle and platelets for the study of mitochondrial transmembrane proteins.The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.Anesthetic Management of a Child With Unspecified Mitochondrial Disease in an Outpatient Dental Setting.Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.Mitochondrial drugs come of age.Mitochondrially Targeted Nanoparticles Based on α-TOS for the Selective Cancer Treatment.Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice.
P2860
Q26771260-248597B1-1489-4840-BF11-2D193E310E22Q26824514-1DFFE01A-D6C9-4A56-84F4-41CF2CD15368Q28078384-177FDAFF-7346-4E60-B754-FAB6D1BEADB6Q28391294-05A4E2AB-3B70-4EE0-99EC-6B40DA242007Q34024641-553467E7-C935-46AC-BB79-833E0236AC38Q35758417-0E5FE25E-BDF4-46A0-B087-7EECC9FCB25EQ37587300-5643BCA5-974C-453D-BCA1-219A24508A8BQ38268573-A62C10CA-EDE3-4489-B2F9-DABB2DA084E2Q38376620-975FE2F2-43B0-4A18-B00C-A1A4E0305CC0Q38801948-EAAFC956-F7CF-4506-A0B7-A8892C55BACDQ38924121-1E028D3E-033B-4299-8757-979145C4E027Q39106411-13D441C0-9D17-4344-BA6E-B52D617B0FC7Q41547478-F00F9719-5262-4C1C-99A9-ADC2A753B2CBQ46322600-9088AA9D-89CE-4B93-87E7-026E72D967DAQ46628896-3127DE40-90E3-4822-BD93-D86F0D73F7E0Q47105521-9D5FD030-735E-45C9-A928-F5BCEECD5251
P2860
Mitochondria as a pharmacological target: magnum overview.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mitochondria as a pharmacological target: magnum overview.
@en
type
label
Mitochondria as a pharmacological target: magnum overview.
@en
prefLabel
Mitochondria as a pharmacological target: magnum overview.
@en
P2860
P356
P1433
P1476
Mitochondria as a pharmacological target: magnum overview.
@en
P2093
Adam Szewczyk
Anna Olszewska
P2860
P304
P356
10.1002/IUB.1147
P577
2013-03-01T00:00:00Z